Express Scripts claims to be the No. 1 company in the mail order prescription business. In this video, Fool analyst Jim Mueller explains the Express Scripts business and the three things investors need to watch. Mail order prescriptions are attracting the attention of big pharma and generics alike, and how well Express Scripts penetrates these markets is critical to its future success.
Free Article
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.